Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Medical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical devices are “providing accurate diagnoses, effective treatments and personalized care through advanced algorithms and patient data analysis.
Healthcare stocks offer a haven for investors amidst the uncertainty. The Fed elected to hold interest rates at a 23-year high between 5.25% and 5.5% to combat persistent inflation.
Intuitive Surgical, Inc. (ISRG) provides specialized robotic surgery equipment that is growing in use and capabilities.
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $422.90, indicating a -1.21% shift from the previous trading day.
Intuitive Surgical can make for a good investment whether you're bullish on healthcare or artificial intelligence. The company recently launched its latest surgical system, which can benefit from advancements in AI.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.
Intuitive Surgical (ISRG) announces the FDA clearance of revised da Vinci Xi and X Labeling on Radical Prostatectomy.